Home

Screener

MNKD

Profile

MannKind Stock Price History and Quote Analysis: Insights for Investors

MannKind Corporation

(NASDAQ:MNKD)

$3.50

-0.02 (-0.57%)

At Close: 4:00 PM

MannKind Stock Price Graph

MannKind Stock Price Today

MannKind Corporation (MNKD) stock declined over -3.31% intraday to trade at $3.5 a share on NASDAQ. The stock opened with a gain of 14.49% at $4.03 and touched an intraday high of $4.06, falling -0.57% against the last close of $3.52. The MannKind Corporation in stock market went to a low of $3.89 during the session.

MannKind Stock Snapshot

$3.52

Prev. Close

943.5 Million

Market Cap

$3.89

Day Low

$4.03

Open

N/A

Number of Shares

$4.06

Day High

N/A

P/E ratio

-0.12

EPS (TTM)

0.55

Cash Flow per Share

N/A

Free Float in %

-0.93

Book Value

1885810.00

Volume

MannKind Stock Price History Chart

Date	Open	High	Low	Close	Volume

Contact Details

30930 Russell Ranch Road
Westlake Village, CA 91362
US

Website:https://www.mannkindcorp.com

Contact #:818 661 5000

About Company

MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocrinologists, and other healthcare providers for the treatment of hypothyroidism. The company has a license and collaboration agreement with United Therapeutics Corporation. It also has an agreement with NRx Pharmaceuticals to develop a dry powder formulation of ZYESAMI (aviptadil), a synthetic form of human vasoactive intestinal peptide to help protect cells against inflammatory conditions. MannKind Corporation was incorporated in 1991 and is headquartered in Westlake Village, California.

Peers

Frequently Asked Questions

What is the current MannKind Corporation (MNKD) stock price?

MannKind Corporation (NASDAQ: MNKD) stock price is $3.50 in the last trading session. During the trading session, MNKD stock reached the peak price of $4.06 while $3.89 was the lowest point it dropped to. The percentage change in MNKD stock occurred in the recent session was -3.31% while the dollar amount for the price change in MNKD stock was -$0.12.

MNKD's industry and sector of operation?

The NASDAQ listed MNKD is part of Biotechnology industry that operates in the broader Healthcare sector. MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes.

Who are the executives of MNKD?

Dr. Michael E. Castagna Pharm.D.
Chief Executive Officer & Director
Ms. Rosabel Realica Alinaya
Vice President of Investor Relations & Treasury
Dr. David B. Thomson
Executive Vice President, Gen. Counsel & Sec.
Ms. Lauren M. Sabella
Executive Vice President & Chief Operating Officer

How MNKD did perform over past 52-week?

MNKD's closing price is 0.49% higher than its 52-week low of $3.31 where as its distance from 52-week high of $5.75 is -0.32%.

How many employees does MNKD have?

Number of MNKD employees currently stands at N/A. MNKD operates from 30930 Russell Ranch Road, Westlake Village, CA 91362, US.

Link for MNKD official website?

Official Website of MNKD is: https://www.mannkindcorp.com

How do I contact MNKD?

MNKD could be contacted at phone #818 661 5000 and can also be accessed through its website. MNKD operates from 30930 Russell Ranch Road, Westlake Village, CA 91362, US.

How many shares of MNKD are traded daily?

MNKD stock volume for the day was 1885810.00 shares. The average number of MNKD shares traded daily for last 3 months was 2.41 Million.

What is the market cap of MNKD currently?

The market value of MNKD currently stands at $943.5 Million with its latest stock price at $3.50 and N/A of its shares outstanding.